Related Experiment Videos
Lamotrigine-induced rash in children
J Dooley1, P Camfield, K Gordon
1Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
Neurology
|January 1, 1996
Summary
A new antiepileptic drug, lamotrigine, caused a rash in five of 68 children. One child developed severe Stevens-Johnson syndrome, highlighting potential risks of this epilepsy medication.
Area of Science:
- Pediatric Neurology
- Dermatology
- Clinical Pharmacology
Background:
- Lamotrigine is a novel antiepileptic medication used in pediatric epilepsy management.
- Assessing the safety profile of new antiepileptic drugs is crucial for clinical practice.
Observation:
- A cohort of 68 children received treatment with lamotrigine.
- Five children (7.35%) developed a rash during lamotrigine treatment.
- One child experienced Stevens-Johnson syndrome while on lamotrigine monotherapy.
Findings:
- The incidence of rash associated with lamotrigine in children was observed to be 7.35%.
- Severe cutaneous adverse reactions, including Stevens-Johnson syndrome, can occur.
- Rash recurrence was noted upon reexposure to lamotrigine, indicating potential hypersensitivity.
Implications:
- Clinicians should be vigilant for dermatological side effects when prescribing lamotrigine to children.
- Early recognition and management of rash are essential to prevent severe outcomes.
- Further research into the mechanisms and risk factors for lamotrigine-induced rash is warranted.